SLC2A3 and acute myeloid leukemia: We are performing ongoing experiments to define the mechanism underlying the decreased expression of GLUT3, and to determine appropriate methods to improve vitamin C-mediated restoration of TET activity by inducing GLUT3 expression in AML cells.